| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |